Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by Shoeon Apr 23, 2013 6:30pm
144 Views
Post# 21291918

RE: RE: RE: RE: Triple from Here?

RE: RE: RE: RE: Triple from Here?

If a spinout then why not 1 share of spinout for each 5 shares held of AMB creating newco with roughly 36 mil outstanding for example? Opening the way for financing at a reasonable venue.

On another note nice test of a flash crash in Dow today explained by misguided tweet of bomb at whitehouse.

My spidey sense suggests to me that perhaps this distribution in some of the heated US stocks is reaching a point where the pro's will begin selling in earnest. Of course jus as Resource has hit the skids the flipside is higher yet :-) Perhaps too soon or risky to short yet, but I'm thinking the pro's will soon see the opportunity to run things down to profit...

I'm thinking Gold will not go down with overall markets and like a blind bat took a 1/2 position in ABX near the lows today. Balsy ahead of earnings tommorow but at somepoint it's gotta be baked in.

As too our lil play here folks afraid to hold for a couple days : 0

Cheers

shoe

 

Bullboard Posts